Provided by Tiger Fintech (Singapore) Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.72
-0.0100-0.58%
Post-market: 1.70-0.0200-1.16%19:58 EDT
Volume:563.44K
Turnover:977.33K
Market Cap:91.96M
PE:-2.58
High:1.79
Open:1.72
Low:1.67
Close:1.73
Loading ...
Jul 15, 2024

Major Issues Report

Form 8-K - Current report
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 26, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 26, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Nov 07, 2023

Major Issues Report

Form 8-K - Current report